VWR International agreed to acquire Peqlab Biotechnologie, including its subsidiaries and operations in the U.S., U.K., Austria, and its Clemens manufacturing operation in Germany. Peqlab is involved in the development, manufacture, and supply of molecular and cell biology reagents, consumables, and instruments for the healthcare and pharmaceutical industries.

“Peqlab is recognized in Germany and beyond as a specialist distributor of life science products, including the Peqlab brand product range,” noted Manuel Brocke-Benz, VWR’s president and CEO.

Last year VWR bought U.S.-based United Biochemicals and Turkey-based Prolab.

Previous articleGalapagos Wins $3.1M to Build Fibrosis Research Platform
Next articleNovartis to Cut or Shift 4,000 Pharma Jobs